HALO
Halozyme Therapeutics, Inc. · Healthcare
Director Mahesh Krishnan sold $548K of Halozyme Therapeutics, Inc.
Sold$547,800
$75.00Price
7,304Shares
−34%Stake
What HALO did after the filing
- The stock from Wed, Jul 1 open, $78.47
- +28.3%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Aug 13 close.
Traded Mon, Jun 29. Filed Tue, Jun 30, 5:25 PM ET, after the close. Returns use the Jul 1 open and the Aug 13 close. Not investment advice.